Herbas VPB

Print
EN | LT
LT - SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION
EN - SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/50 (2006.01)
A61K 9/5026 (2013.01)
C12N 9/86 (2006.01)
A61K 9/5078 (2013.01)
A61P 1/00 (2006.01)
A61K 38/50 (2013.01)
A61K 45/06 (2006.01)
A61K 31/546 (2013.01)
A61K 9/50 (2006.01)
A61K 45/06 (2013.01)
A61K 31/546 (2006.01)
C12Y 305/02006 (2013.01)
A61P 1/00 (2018.01)
Y02A 50/30 (2018.01)
European patent
(11) Number of the document 3265119
(13) Kind of document T
(96) European patent application number 16762286.9
Date of filing the European patent application 2016-03-07
(97) Date of publication of the European application 2018-01-10
(45) Date of publication and mention of the grant of the patent 2023-10-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2016/021152
Date 2016-03-07
PCT application publication
(87) Number WO 2016/144856
Date 2016-09-15
Priority applications
(30) Number Date Country code
201562129199 P 2015-03-06 US
201562167006 P 2015-05-27 US
201562260979 P 2015-11-30 US
Inventors
(72)
SLIMAN, Joseph , US
Grantee
(73) Theriva Biologics, Inc. , 9605 Medical Center Drive Suite 270, Rockville, MD 20850, US
Title
(54) SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION
  SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION